Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Springworks Therapeutics Inc (SWTX)

Springworks Therapeutics Inc (SWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
SpringWorks Gets CHMP Nod for Mirdametinib in Rare Disease
SpringWorks Gets CHMP Nod for Mirdametinib in Rare Disease Zacks Investment Research - Mon May 26, 11:38AM CDT

SpringWorks Therapeutics SWTX announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has rendered a positive opinion recommending conditional marketing...

LXRX : 0.6715 (-3.49%)
AMRN : 13.25 (-0.97%)
HALO : 53.98 (-1.03%)
SWTX : 46.78 (+0.04%)
SpringWorks Therapeutics Receives Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PN GlobeNewswire - Fri May 23, 7:00AM CDT

SWTX : 46.78 (+0.04%)
SpringWorks Therapeutics: Q1 Earnings Snapshot AP - Fri May 9, 3:36PM CDT

SpringWorks Therapeutics: Q1 Earnings Snapshot

SWTX : 46.78 (+0.04%)
Merck KGaA, Darmstadt, Germany to Acquire SpringWorks Therapeutics to Accelerate Sustainable Growth of Healthcare Business GlobeNewswire - Mon Apr 28, 1:13AM CDT

SWTX : 46.78 (+0.04%)
SpringWorks Therapeutics Announces Expected CHMP Opinion in Q2 2025 for Nirogacestat for the Treatment of Adults with Desmoid Tumors in the European Union GlobeNewswire - Sun Apr 27, 9:35AM CDT

SWTX : 46.78 (+0.04%)
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week Stocktwits - Sun Mar 16, 8:56PM CDT

Positive data from clinical trials, earnings readouts, M&A speculation and new research drew heavy interest from retail traders on Stocktwits for these tickers for the week ended March 14, 2025.

TNYA : 0.5915 (-1.55%)
CSCI : 3.57 (-1.24%)
MLYS : 14.32 (-4.02%)
SWTX : 46.78 (+0.04%)
MGX : 1.4300 (-1.38%)
SpringWorks Therapeutics Leads Biotech Pack In Weekly Retail Follower Surge: What's Fueling Interest? Stocktwits - Mon Mar 10, 3:52AM CDT

Investor attention is now on whether Merck will confirm a formal offer as speculation over a potential acquisition continues dominating discussions around the stock.

VTI : 293.57 (-1.18%)
XBI : 83.60 (-0.90%)
IWM : 208.92 (-1.81%)
SWTX : 46.78 (+0.04%)
SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Updates GlobeNewswire - Thu Feb 20, 5:30AM CST

SWTX : 46.78 (+0.04%)
SpringWorks Therapeutics Gains Retail Interest Ahead Of Q4 Earnings – What Investors Expect Stocktwits - Wed Feb 19, 11:36PM CST

Recent investor enthusiasm has been fueled by reports that German healthcare giant Merck KGaA is in advanced talks to acquire SpringWorks.

VTI : 293.57 (-1.18%)
XBI : 83.60 (-0.90%)
IWM : 208.92 (-1.81%)
SWTX : 46.78 (+0.04%)
UPDATE: SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN  GlobeNewswire - Tue Feb 11, 7:20PM CST

SWTX : 46.78 (+0.04%)

Barchart Exclusives

Oil Price Predictions: The Case for Crude Prices to Surge to $130 Here Barchart - 47 minutes ago
JPMorgan says oil prices will likely remain in the low- to mid-$60 range despite the Israel-Iran conflict. But the worst-case scenario could push Brent crude up to $130. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot